The US Food and Drug Administration approved WELIREG in combination with LENVIMA for certain previously treated adult patients with advanced renal cell carcinoma with clear cell components.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.